FGF10人重组蛋白

蛋白名称:FGF10人重组蛋白，10573-HNAE

蛋白构建:A DNA sequence encoding the mature form of human FGF10 (NP_004456.1) (Gln38-Ser208) was expressed with an N-terminal Met.

表达宿主:E. coli

蛋白纯度:≥ 95 % as determined by SDS-PAGE. ≥ 95 % as determined by SEC-HPLC.

蛋白活性:

1.Measured in a cell proliferation assay using BaF3 mouse pro-B cells transfected with human FGFR2b. The * for this effect is typically 3-30 ng/mL.

2.Human lung cancer organoids were cultured with FGF2(Cat#10014-HNAE), FGF4(Cat#16043-HNAE), FGF7(Cat#10210-H07E), EGF(Cat#50482-MNCH), FGF10(Cat#10573-HNAE), NOG(Cat#50688-M02H), RSPO1(Cat#11083-HNAS). (Routinely tested). Data provided by D1 Medical Technology.

3.Human lung organoids were cultured with FGF2(Cat#10014-HNAE), FGF4(Cat#16043-HNAE), FGF7(Cat#10210-H07E), EGF(Cat#50482-MNCH), FGF10(Cat#10573-HNAE), NOG(Cat#50688-M02H), RSPO1(Cat#11083-HNAS). (Routinely tested). Data provided by D1 Medical Technology.

4.Human cholangiocarcinomas organoids were cultured with FGF2(Cat#10014-HNAE), HGF(Cat#10463-HNAS), FGF7(Cat#10210-H07E), EGF(Cat#50482-MNCH), FGF10(Cat#10573-HNAE), NOG(Cat#50688-M02H), RSPO1(Cat#11083-HNAS). (Routinely tested). Data provided by D1 Medical Technology.

5.Human liver cancer organoids were cultured with FGF2(Cat#10014-HNAE), HGF(Cat#10463-HNAS), FGF7(Cat#10210-H07E), EGF(Cat#50482-MNCH), FGF10(Cat#10573-HNAE), TGFB1(Cat#10804-HNAC), NOG(Cat#50688-M02H), RSPO1(Cat#11083-HNAS). (Routinely tested). Data provided by D1 Medical Technology.

6.Human kidney cancer organoids were cultured with FGF2(Cat#10014-HNAE), FGF7(Cat#10210-H07E), EGF(Cat#50482-MNCH), FGF10(Cat#10573-HNAE), NOG(Cat#50688-M02H), RSPO1(Cat#11083-HNAS). (Routinely tested). Data provided by D1 Medical Technology.

7.Human kidney organoids were cultured with FGF7(Cat#10210-H07E), EGF(Cat#50482-MNCH), FGF10(Cat#10573-HNAE), NOG(Cat#50688-M02H), RSPO1(Cat#11083-HNAS), HGF(Cat#10463-HNAS), FGF4(Cat#16043-HNAE). (Routinely tested). Data provided by D1 Medical Technology.

8.Human gastric cancer organoids were cultured with EGF(Cat#50482-MNCH), FGF10(Cat#10573-HNAE), NOG(Cat#50688-M02H), RSPO1(Cat#11083-HNAS). (Routinely tested). Data provided by D1 Medical Technology.

9.Human stomach organoids organoids were cultured with EGF(Cat#50482-MNCH), FGF10(Cat#10573-HNAE), NOG(Cat#50688-M02H), RSPO1(Cat#11083-HNAS). (Routinely tested). Data provided by D1 Medical Technology.

10.Human small intestinal organoids were cultured with IL22(13059-HNAE), FGF10(10573-HNAE), EGF(50482-MNCH), NOG(50688-M02H). (Routinely tested). Data provided by D1 Medical Technology.

蛋白内毒素:< 5 EU per mg of the protein.

预测N端:Met

蛋白分子量:The recombinant human FGF10 consists of 172 amino acids and has a predicted molecular mass of 19.46 kDa as estimated in SDS-PAGE under reducing conditions.

蛋白NP号:NP_004456.1

蛋白氨基酸序列:Gln38-Ser208

蛋白标签:Native

欢迎去义翘神州网查看FGF10人重组蛋白，10573-HNAE详细信息。网址：https://cn.sinobiological.com/recombinant-proteins/human-fgf10-10573-hnae

义翘神州研发团队拥有多年的重组蛋白研发经验。多年来，我们的团队已开发出超过9300余种重组蛋白，涵盖免疫检查点、抗体药物靶点、CAR-T细胞治疗靶点、Fc受体、流感病毒蛋白以及细胞因子等热门研究领域。义翘神州重组蛋白具有高纯度、高生物活性和低内毒素水平等特性，可为生物药靶点发现、蛋白质结构和功能分析、细胞疗法和重组酶酶学性质等科学研究提供支持。

义翘神州利用蛋白表达平台，提供重组蛋白生产"一站式"技术服务。我们的服务包括蛋白基因合成、蛋白质密码子优化、蛋白质表达载体设计、大规模细胞培养和发酵、蛋白纯化和蛋白质量控制检测。我们在蛋白表达和大规模生产方面有着显著的成本节约和速度优势，同时在设计各种类型的重组蛋白纯化项目（带或不带纯化标签）方面也拥有着丰富的经验和专业技术。 义翘神州拥有经验丰富的技术团队，每年可研发生产1,000+种重组蛋白开发和大规模生产项目。我们有能力进行快速的蛋白质表达和纯化工艺开发，根据需求进行工艺放大研究，并且可满足高通量和大规模批量生产蛋白质的要求。 我们致力于成为重组蛋白和单克隆抗体大规模生产的实验室，为药物研发企业和生命科学机构提供高水平的技术服务。

欢迎小伙伴来咨询哦!  请注明来源、姓名，单位！

关注义翘神州或添加微信“sinobio2023"进行联系！